Suzhou Ribo Life Science Co., Ltd. (HKG:6938)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
57.40
-0.30 (-0.52%)
Sep 10, 2026, 11:37 AM HKT

Suzhou Ribo Life Science Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Suzhou Ribo Life Science stock has a consensus rating of "Strong Buy" and an average price target of $100.07. The average 1-year stock price forecast is 74.34% higher than the current stock price, while the lowest is $90.02 (+56.83%) and the highest is $108.19 (+88.48%).

Price Target: $100.07 (+74.34%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$90.02$100.07$100.54$108.19
Change+56.83%+74.34%+75.16%+88.48%

Analyst Ratings

The average analyst rating for Suzhou Ribo Life Science stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy244445
Buy000011
Hold000000
Sell000000
Strong Sell000000
Total244456

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
CICC
No rating
CICC
Buy
Maintains
$90.00
BuyMaintains$90.00+56.79%Sep 3, 2026
Unknown Analyst
Guotai Haitong
No rating
Guotai Haitong
Buy
Maintains
$105.20
BuyMaintains$105.20+83.28%Jul 17, 2026
Unknown Analyst
Soochow Securities
No rating
Soochow Securities
Buy
Maintains
$115.80
BuyMaintains$115.80+101.74%May 20, 2026
Unknown Analyst
Citi
No rating
Citi
Buy
Maintains
$102.00
BuyMaintains$102.00+77.70%Mar 30, 2026
Unknown Analyst
Shenwan Hongyuan
No rating
Shenwan Hongyuan
Buy
Maintains
$86.08
BuyMaintains$86.08+49.97%Mar 6, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
485.83M
from 148.51M
Increased by 227.13%
Revenue Next Year
244.86M
from 485.83M
Decreased by -49.60%
EPS This Year
-0.96
from -1.97
EPS Next Year
-1.67
from -0.96
Fiscal YearFY 2018FY 2019FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2018Dec 31, 2019Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
--44.00K142.63M148.51M485.83M
Revenue Growth
---324,052.27%4.13%227.13%
Gross Profit
-2.44M-1.96M-24.98M115.65M121.73M441.25M
Gross Margin
---56,777.27%81.09%81.96%90.83%
Operating Income
-111.57M-140.39M-422.49M-258.34M-279.32M-106.55M
Net Income
-98.66M-134.35M-428.35M-270.15M-278.06M-180.89M
EPS
-----1.97-0.96
Free Cash Flow
-80.44M-94.17M--49.05M-119.42M-48.33M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High594.7M
Avg485.8M
Low324.4M

Revenue Growth

Revenue Growth202620272028
High
300.5%
Avg
227.1%
Low
118.4%

EPS Forecast

EPS202620272028
High-0.81
Avg-0.96
Low-1.10

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-